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In the preceding paper a  description was given of the preparation and 
properties  of  a  soluble  agent,  extracted from cultures of an  unidentified 
soil  bacillus,  which exerts  a  bactericidal  effect on  Gram-positive  micro- 
organisms  (1).  The  bactericidal  effect in  vitro  is  not  inhibited  by  the 
presence of serum or ascitic fluid;  in  fact,  the  bactericidal agent  is  also 
effective in vivo.  Its protective action against experimental pneumococcus 
infections in mice is described in the present paper. 
EXPERIMENTAL 
Cultures.--Virulent  pneumococci of Types I, II, III, V, VIII, and virulent Fried- 
l~nder bacilli type B were grown in blood broth and passed through mice often enough 
to maintain a degree of virulence such that 0.000,000,01 cc. of an 8 hour culture would 
regularly kill 20 gm. mice within 72 hours.  In all cases,  the infective dose, diluted in 
0.5 cc. of buffer pH 7.4, was injected by the intra-abdominal route. 
Bactericidal Agent.--All  the protection experiments reported in  the  present paper 
were carried out with the same preparation of the bactericidal agent (NS7)  which was 
used in the experiments described in the preceding paper.  The agent was injected by 
the intra-abdominal route in the form of a solution in phosphate buffer at pH 7.4.  The 
dilutions were so arranged that the desired amount of agent was administered in 0.5 cc. 
of buffer solution. 
Protective Effect of a Single Dose of the Bactericidal Agent.--Mice were infected with 
varying dilutions of cultures of virulent pneumococci (Type I  and Type III) and were 
subsequently treated within 10 minutes with 2 mg. of the bactericidal agent.  No further 
treatment  was given  (Table I). 
The  results  presented  in  Table  I  show  that  one  single  treatment  with 
2  mg.  of  the  bactericidal  substance  was  sufficient  to  protect  a  significant 
number of mice against infection with 0.0001  and 0.00001  cc. of culture of 
virulent  pneumococci.  Although  most  of  the  mice  infected  with  larger 
amounts  of  culture  died  within  the  6  day  observation  periods,  they  sur- 
11 12  BACTERICIDAL  AGENT  FROM  SOIL BACILLUS.  II 
vived longer than the untreated controls.  The next experiment aimed at 
determining  whether  a  higher degree of protection could be obtained  by 
administering  the  bactericidal extract  repeatedly at  24  hour  intervals. 
Protective Effect of Repeated Doses of the Bactericidal Agent.--Mice were inoculated 
with 0.1 or 0.01 cc. of cultures of virulent pneumococci Types I, II, III, V, VIII.  They 
were treated on 3 consecutive days; 2 rag. of the bactericidal agent was given 10 minutes 
after injection of the infective inoculum,  1 rag. 24 hours later, and i mg. 48 hours later 
(Table II.) 
TABLE I 
Protective Effect of a Single Dose of Bactericidal Substance 
Infective dose of pneumococcus  Result* 
Type I 
4C 
~C 
C~ 
Type III 
c~ 
c~ 
c~ 
cc 
L~ 
0.01 
0.001 
0.000,1 
0.000,01 
0.000,001 
0.000,000,1 
0.000,000,01 
0.01 
0.001 
0.000,.1 
0.000,01 
0.000,001 
0.000,000,1 
0.000,000,01 
Treat-  Number 
ment  of mice 
--gU.  -- 
2  6 
2  6 
2  6 
0  ! 
0  1 
0  ! 
2  6 
2  6 
2  6 
2  6 
0,  ! 
0  1 
0  1 
D  48 
D 72 
D 72 
S 
D44 
D46 
D 72 
D48 
D 72 
D 72 
D 72 
D46 
D44 
D44 
D72  D72  D72  D72  S 
D72  D96  S  S  S 
S  S  S  S  S 
S  S  S  S  S 
D48  D72  D72  D72  D72 
D72  D72  D96  D96  D96 
D96  D96  S  S  S 
D96  S  S  S  S 
*S  =  survival of the animal (6 day observation periods). 
D  =  death of the animal; the numeral indicates number of hours before death. 
The results presented in  Table II show that,  with 3  consecutive treat- 
ments at 24 hour intervals of time and comprising in all 4 rag. of agent, it 
was possible to protect many mice against  0.1  and 0.01  cc. of cultures of 
pneumococci of maximum virulence; in all cases the untreated control mice, 
inoculated  with 0.000,000,01  cc.  of culture or with larger infective doses, 
died in  less  than  72  hours. 
In order to study the comparative effectiveness of the bactericidal agent 
against the different types of pneumococci, an effort was made in the follow- 
ing experiment to determine the minimal amount of agent that would pro- 
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Titration of the Bactericidal  Agent against Different Types of Pneumococci.--Groups of 
4 mice each were inoculated  with 0.001 cc. of 8 hour cultures  of pneumococci of Types 
I, II, III, V, VIII.  Within 10 minutes after inoculation  each group was treated with 
1 rag., 0.3 rag., or 0.1 rag. respectively of the bactericidal  agent.  A second treatment 
with the same amount of extract (1 rag., 0.3 rag., and 0.1 nag. respectively)  was again 
given 24 hours later and the same dose repeated 48 hours after inoculation  (Table III). 
TABLE LI 
Protective Effect of Repeated Treatments  with the Bactericidal  Agent 
Infective dose of pneumococcus 
Type I 
~c 
c~ 
Type II 
cc 
cc 
Type III 
~c 
gc 
Type V 
~¢ 
Typ,e VIII 
0.1 
0.01 
0.000,000,01 
0.1 
0.01 
0.000,000,01 
0.1 
0.01 
0.000,000,01 
0.1 
0.01 
0.000,000,01 
0.1 
0.01 
0.000,000,01 
Treatment on 3  Num- 
consecutive days  ber of  Results 
mice 
mg.  mg.  mg. 
2  1  1 
2  1  1 
0  0  0 
2  1  1 
2  1  1 
0  0  0 
2  1  1 
2  1  1 
0  0  0 
2  1  1 
2  1  1 
0  0  0 
2  1  1 
2  1  1 
0  0  0 
6  D22  S  S  S  S  S 
6  D22  S  S  S  S  S 
1"  D 40 
6  D26  S  S  S  S  S 
6  D22  S  S  S  S  S 
1"  D 72 
6  D72  D72  D72  D72  S  S 
6  D72  D72  S  S  S  S 
1"  D 60 
6  D72  S  S  S  S  S 
6  S  S  S  S  S  S 
1"  D 72 
6  D22  D22  D40  D48  S  S 
6  D22  S  S  S  S  S 
1"  D 40 
* The untreated  control animals  inoculated with  0.000,000,1 and  0.000,001 cc.  of 
culture died within  44 hours. 
It is apparent from the results presented in Table III that 1 mg. of extract 
administered  daily  on  3  consecutive  days  was  sufficient  to  protect  mice 
against infection with 0.001  cc. of culture of pneumococci Types I, II, III, 
V, VIII.  When the amount of extract was reduced to 0.3 rag. or 0.1  mg. 
daily, most animals died within the 6 day observation period, although they 
survived longer than  the  controls.  One may conclude therefore,  that the 
protective effect of the bactericidal agent is approximately the same against 
all virulent pneumococci so far tested,  irrespective of specific type. 
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of bactericidal agent was administered within 10 to 15 minutes after inocula- 
tion  of  the  experimental  animals  with  the  infecting  organism.  In  the 
following experiment an attempt  was made to determine the curative effect 
of the bactericidal agent when administered several hours after injection of 
the  infecting  inoculum. 
TABLE  III 
Titration  of the  Bactericidal  Agent  against  Pneumococci  of Different  Types 
Infective dose  of 
pneumococcus 
Type I 
~c 
Type II 
gc 
Type III 
Type V 
Type VIII 
lc 
lc 
Treatment 
CC. 
01001  1.0  1.0 
"  0.3  0.3 
"  0.1  0.1 
"  0  0 
0.001  1.0  1.0 
"  0.3  0.3 
"  0.1  0.1 
"  0  0 
0.001  1.0  1.0 
"  0.3  0.3 
"  0.1  0.1 
"  0  0 
0.001  1.0  1.0 
"  0.3  0.3 
"  0.1  0.1 
"  0  0 
0.001  1.0  1.0 
"  0.3  0.3 
"  0.1  0.1 
"  0  0 
rag. of agent per day 
1.0 
0.3 
Nt mber  I 
of mice' 
4 
4 
0.1  4 
0  4 
1.0  4 
0.3  4 
0.1  4 
0  4 
1.0  4 
0.3  4 
0.1  4 
0  4 
1.0  4 
0.3  4 
0.1  4 
0  4 
1.0  4 
0.3  4 
0.1  4 
0  4 
Results 
S  S  S  S 
D72  D96  D120  S 
D72  D72  D96  D96 
D24  D24  D48  D48 
S  S  S  S 
D 72  D 96  D 96  D 120 
D 72  D 72  D 96  D 96 
D 24  D 24  D 48  D 48 
D 120  S  S  S 
D 72  D 95  D 96  D 96 
D 48  D 72  D 72  D 72 
D 24  D 24  D 48  D 48 
S  S  S  S 
D96  D120  D120  S 
D 72  D 72  D 96  D 96 
D 48  D 48  D 48  D 48 
D120  S  S  S 
D72  D96  D96  D96 
D48  D48  D72  D72 
D24  D24  D24  D24 
The Curative Effect of the Bactericidal Agent.--Mice were inoculated with 0.000,01  cc. 
of culture of Type I  or Type III.  They were divided into three groups  which were 
treated with 2 rag. of bactericidal agent respectively 2 hours, 5 hours, and 17 hours after 
infection.  A second and a  third dose of 1 rag. each, were given 24 and 48 hours after 
the first treatment (Table IV). 
The results presented in Table III  show that  mice inoculated with  1000 
fatal doses of pneumococci Type I  or Type III  can be protected even when 
treatment  with  the  bactericidal  agent  is  delayed  for  several  hours  after REN~J.  DUBOS  15 
infection.  In fact, 3 out of 6 mice inoculated with Type I  organisms sur- 
vived,  although treatment had  been  delayed for  17  hours;  the  6  mice 
inoculated with Type III pneumococci and treated 17 hours later all died, 
but 4 of them survived much longer than the untreated controls. 
The Effect of the Bactericidal  Agent upon Infection with Klebsiella  pneu- 
moniae.--It  has been shown in the preceding paper that the bactericidal 
agent is  ineffective in vitro against  all  the  Gram-negative bacilli  so  far 
tested.  It  is  also  ineffective upon  experimental  infection of  mice  with 
TABLE IV 
Curative Effect of the Bactericidal Agent 
Infective  dose  of pneumococcus 
Type I 
c~ 
t~ 
Type III 
(c 
c{ 
t( 
cG, 
0.000,01 
~c 
cc 
c¢ 
~C 
0.000,000,01 
0.000,01 
~t 
C~ 
0.000,000,01 
Time between infection  and first treatment 
2hrs. 
S 
S 
S 
S 
S 
S 
D 96 
S 
S 
S 
S 
S 
$ hrs. 
S 
S 
S 
S 
S 
S 
D 72 
D 96 
S 
S 
S 
S 
17 hrs. 
D34 
D 72 
D 96 
S 
S 
S 
D 24 
D 30 
D 48 
D60 
D 72 
D 96 
No treatment 
D 30 
D 34 
D40 
D 72 
D 18 
D 30 
D 34 
D 48 
KlebsieUa  pneumoniae  (FriedlAnder  bacillus),  a  Gram-negative  rod,  as 
appears  from the  following experiment. 
Mice were inoculated with dilutions of a 6 hour culture of Friedl~inder  bacilli type B. 
They were treated within 5 minutes with 2 rag. of preparation NS7 (Table V). 
DISCUSSION 
It is clear that the bactericidal agent described in the preceding paper is 
effective in vivo as well as in vitro and protects mice against infection with 
virulent pneumococci.  In fact, the protective action is observed not only 
when the agent is injected simultaneously with the infective dose, but also 
when  it  is  administered  several  hours  later. 16  BACTERICIDAL AGENT FROM  SOIL BACILLUS.  II 
Protection has been obtained against cultures of the five different types 
of pneumococci (I, 1I, III, V, VIII) which have been used; these cultures 
were of maximum virulence since 0.000,000,01  cc. was invariably fatal to 
mice within 72 hours.  It is permissible to assume, therefore, that the agent 
will be found effective against experimental infection of mice with pneumo- 
cocci of other types. 
It is of special interest that the amount of bactericidal agent required to 
protect mice against a  given amount of virulent culture is approximately 
the same irrespective of the type of pneumococcus used as infective agent. 
It  is likely,  therefore,  that  the  action  of the  agent is directed against  a 
structure or a function which is qualitatively and quantitatively similar in 
all pneumococci.  The same conclusion had been derived from a  study of 
TABLE V 
Effect of the Bactericidal Agent upon Experimental Infection of Mice with KlebsieUa 
~neumoniae 
Infective dose of Kl#bsiella  Treatment  Number of mice  Result  pneumoniae type B 
0.000,1 
0.000,01 
0.000,001 
0.000,000, I 
0.000,000,01 
mg. 
2 
2 
2 
0 
0 
DI7  DI7  DI7  DI7 
DI7  DI7  DI7  D72 
DI7  DI7  DI7  D48 
D 48  D 72 
D72  D72 
the action of the agent on pneumococci in vitro.  As will be shown in a later 
publication, experiments carried out in collaboration with Dr. R. C. Lance- 
field have  demonstrated that  the agent also exerts a  protective effect on 
experimental infection of mice with hemolytic streptococci of group A and 
C; on the contrary, it does not protect mice against Klebsiella pneumoniae, 
a  Gram-negative organism, even when very small infective doses are used. 
This,  again,  is  in  agreement  with  the  results  of  experiments  in  vitro  in 
which  a  bactericidal  effect was  recognized against  all  the  Gram-positive 
microorganisms so far tested, whereas the Gram-negative bacilli remained 
unaffected.  There is little doubt,  therefore, that the protective effect in 
vivo  depends upon the  same mechanism by  which the bactericidal  agent 
causes the death of the  Gram-positive  cells in  vitro.  It  is interesting  to 
contrast this direct bactericidal effect with the mechanism of the protection 
induced by a bacterial enzyme that hydrolyzes the capsular polysaccharide z~z~5, Dwos  17 
of Type III Pneumococcu~ (2,  3).  As  described in  earlier  studies,  this 
polysaccharidase does not in anY way affect the viability of pneumococci; 
by decomposing the capsular substance of Type III organisms, however, 
it renders these bacterial cells  susceptible to destruction by phagocytosis. 
The polysaccharidase does not attack the specific polysaccharides of other 
types of pneumococci, and consequently it protects only against infection 
with Type III organisms.  On the contrary,  the bactericidal agent con- 
sidered in the present paper inhibits the growth of all Gram-positive or- 
ganisms so far tested, and exerts on them a  direct bactericidal action in 
vitro  and in  vivo. 
SUMMARY 
In the first paper of this series,  a  description was given of a  ceil-free 
extract, obtained from autolysates of a particular strain of a soil bacillus, 
which selectively inhibits the growth of all the Gram-positive microorgan- 
isms so far tested, and exerts on them a  bactericidal effect in vitro. 
In the present study it is shown that the same agent protects white mice 
against  infection with  large  numbers of  virulent  pneumococci.  It  also 
exerts a  curative effect when administered to mice several hours after in- 
jection of the infecting organisms. 
The  degree  of protection afforded,  and  the  minimal effective dose of 
bactericidal agent, are approximately the same for all virulent pneumococci, 
irrespective of type specificity. 
The  bactericidal  agent  is  entirely  ineffective  against  infection  with 
virulent Friedl~tnder bacilli  (type B).  This agrees with the fact that the 
agent does not affect Gram-negative bacilli in vitro. 
The  protective  action  exerted  by  the  bactericidal  agent  against  ex- 
perimental  pneumococcus infection depends  upon  the  same  mechanism 
which determines its bactericidal effect in vitro. 
See Addendum to Paper  I. 
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